Show simple item record

Preventing neural tube defects in Europe: population based study.

dc.contributor.authorBusby, Araceli
dc.contributor.authorAbramsky, Lenore
dc.contributor.authorDolk, Helen
dc.contributor.authorArmstrong, Ben
dc.date.accessioned2014-07-25T14:07:34Z
dc.date.available2014-07-25T14:07:34Z
dc.date.issued2005-03-12
dc.identifier.citationBusby A et al. Preventing neural tube defects in Europe: population based study. 2005, 330 (7491):574-5 BMJen_GB
dc.identifier.issn1756-1833
dc.identifier.pmid15760997
dc.identifier.doi10.1136/bmj.330.7491.574
dc.identifier.urihttp://hdl.handle.net/10147/323826
dc.descriptionEach year, more than 4500 pregnancies in the European Union are affected by neural tube defects. Unambiguous evidence of the effectiveness of periconceptional folic acid in preventing neural tube defects has been available since 1991,1 and improving folate status sufficiently could result in the prevention of more than two thirds of all neural tube defects. We report on trends in the prevalence of neural tube defects up to 2001, in the context of a survey in 16 European countries of periconceptional folic acid policies and their implementationen_GB
dc.language.isoenen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC554030/en_GB
dc.rightsArchived with thanks to BMJ (Clinical research ed.)en_GB
dc.subjectFOLIC ACIDen_GB
dc.subjectPOPULATION BASED AND PREVENTIVE SERVICESen_GB
dc.subject.meshEurope
dc.subject.meshHumans
dc.subject.meshInfant, Newborn
dc.subject.meshNeural Tube Defects
dc.subject.meshPrevalence
dc.subject.meshRegistries
dc.subject.otherNEURAL TUBE DEFECTSen_GB
dc.titlePreventing neural tube defects in Europe: population based study.en_GB
dc.typeArticleen
dc.contributor.departmentLondon School of Hygiene and Tropical Medicine, London WC1E 7HT. araceli.busby@lshtm.ac.uken_GB
dc.identifier.journalBMJ (Clinical research ed.)en_GB


This item appears in the following Collection(s)

Show simple item record